The impact of immunotherapeutic agents targeting specific genes, such as anti-IL-7R 13, anti-IL-6 15 and immune checkpoint inhibitors 16, their effect on cancer and autoimmune diseases is receiving extensive scrutiny. Here, IL6 is linked to cancer.